Acetazolamide NDC 62332-349

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-349Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0349Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62332-349-31	62332034931	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-349-31)Marketed from Feb 20, 2019
62332-349-91	62332034991	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62332-349-91)Marketed from Feb 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acetazolamide
Generic name (nonproprietary): acetazolamide
Active ingredients: Acetazolamide — 500 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210423
Marketing start: Feb 20, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers: Product ID 62332-349_5e12d289-e62f-4b85-a419-ec24a39049baSPL ID 5e12d289-e62f-4b85-a419-ec24a39049baSPL set ID 43231abb-2a5d-44ab-b3e6-7564a1131ac5RxCUI 562524UNII O3FX965V0IUPC 0362332349319
Pharmacologic class: Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332034931 followed by a unit qualifier and the quantity

Package 62332-0349-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 30, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE: For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide extended-release capsules are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210423

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210423
Product	Strength	Form · route	Labeler	Product NDC
Acetazolamide	Acetazolamide 500 mg/1	Capsule, Extended releaseOral	Alembic Pharmaceuticals Limited	46708-349